Inoperable Non Small Cell Lung Cancer Clinical Trial
Official title:
A Phase I Study of Premetrexed (Alimta) and Carboplatin and Radiation Therapy in Patients With Inoperable Non Small Cell Lung Cancer.
To determine the safety of Alimta when used with chemoradiation in inoperable non small cell lung cancer
To determine the maximal tolerated dose (MTD) and toxicities of Pemetrexed (Alimta) when
administered concurrently with carboplatin and thoracic radiation therapy.
To determine, qualitatively, the occurrence of local tumor responses identified with this
regimen.
;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment